LLY

911.03

-1.26%↓

JNJ

186.52

-0.04%↓

UNH

318.33

-1.31%↓

NVS

126.12

-0.3%↓

ABT

125.4

+0.72%↑

LLY

911.03

-1.26%↓

JNJ

186.52

-0.04%↓

UNH

318.33

-1.31%↓

NVS

126.12

-0.3%↓

ABT

125.4

+0.72%↑

LLY

911.03

-1.26%↓

JNJ

186.52

-0.04%↓

UNH

318.33

-1.31%↓

NVS

126.12

-0.3%↓

ABT

125.4

+0.72%↑

LLY

911.03

-1.26%↓

JNJ

186.52

-0.04%↓

UNH

318.33

-1.31%↓

NVS

126.12

-0.3%↓

ABT

125.4

+0.72%↑

LLY

911.03

-1.26%↓

JNJ

186.52

-0.04%↓

UNH

318.33

-1.31%↓

NVS

126.12

-0.3%↓

ABT

125.4

+0.72%↑

Kodu・Aktsiate loetelu・Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc

Avatud

SektorTervishoid

1.23 -12.14

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.18

Max

1.42

Põhinäitajad
By Trading Economics
Sissetulek	29M 3.3M
Müük	28M 29M
Kasumimarginaal	11.266
Töötajad	103
EBITDA	31M 5.7M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+66.67% upside

Turustatistika
By TradingEconomics
Turukapital	87M 494M
Eelmine avamishind	13.37
Eelmine sulgemishind	1.23

Uudiste sentiment

By Acuity

68%

32%

331 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

0.6863 / 0.72 Toetus ja vastupanu

Lexicon Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. nov 2025, 23:38 UTC

Tulu

OCBC Posts Steady Third-Quarter Net Profit, Drop in Net Interest Income

6. nov 2025, 23:00 UTC

Tulu

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts -- Update

6. nov 2025, 22:19 UTC

Tulu

Suurimad hinnamuutused turgudel

Block Shares Slide After 3Q Results Miss Estimates

6. nov 2025, 21:53 UTC

Tulu

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts

6. nov 2025, 23:45 UTC

Tulu

Wheaton Precious Metals 3Q Sales $476M >WPM

6. nov 2025, 23:45 UTC

Tulu

Wheaton Precious Metals 3Q Adj EPS 61.8c >WPM

6. nov 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. nov 2025, 23:45 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stocks Drop

6. nov 2025, 23:45 UTC

Tulu

Wheaton Precious Metals 3Q EPS 80.7c >WPM

6. nov 2025, 23:38 UTC

Market Talk

Gold Edges Higher Amid Worrisome Signs for U.S. Economy -- Market Talk

6. nov 2025, 23:15 UTC

Tulu

Kakao 3Q Net Profit Beat FactSet-Compiled Consensus

6. nov 2025, 23:14 UTC

Tulu

Kakao 3Q Net KRW192.86B Vs. Net KRW78.51B >035720.SE

6. nov 2025, 23:14 UTC

Tulu

Kakao 3Q Oper Pft KRW208.05B Vs. Pft KRW130.53B >035720.SE

6. nov 2025, 23:13 UTC

Tulu

Kakao 3Q Rev KRW2.087T Vs. KRW1.921T >035720.SE

6. nov 2025, 23:08 UTC

Tulu

Oversea-Chinese Banking Corp. 3Q Total Income S$3.80B Vs. S$3.80B >O39.SG

6. nov 2025, 23:08 UTC

Tulu

Oversea-Chinese Banking Corp. 3Q Noninterest Income S$1.57B Vs. S$1.37B >O39.SG

6. nov 2025, 23:07 UTC

Tulu

Oversea-Chinese Banking Corp. 3Q Net S$1.98B Vs. Net S$1.97B >O39.SG

6. nov 2025, 23:07 UTC

Tulu

Suzano 3Q Rev BRL12.2B >SUZ

6. nov 2025, 22:47 UTC

Omandamised, ülevõtmised, äriostud

Wheaton Precious Metals to Pay Waterton Gold $670M Up Front

6. nov 2025, 22:47 UTC

Omandamised, ülevõtmised, äriostud

Wheaton Precious Metals to Buy Gold Stream on Spring Valley Project Located in Nevada >WPM

6. nov 2025, 22:45 UTC

Omandamised, ülevõtmised, äriostud

Union Pacific and Norfolk Southern Provide Supplemental Disclosures to Joint Proxy Statement About Merger

6. nov 2025, 22:25 UTC

Omandamised, ülevõtmised, äriostud

At Bank of America's Investor Day, M&A Hints, Would-Be CEOs, and AI Pitches -- Barrons.com

6. nov 2025, 22:13 UTC

Tulu

Fairfax Financial 3Q Rev $8.27B >FFH.T

6. nov 2025, 22:02 UTC

Tulu

Century Aluminum 3Q Sales $632.2M >CENX

6. nov 2025, 22:02 UTC

Tulu

Century Aluminum 3Q Adj EPS 56c >CENX

6. nov 2025, 21:53 UTC

Tulu

DraftKings Stock Sinks on Disappointing Results -- Barrons.com

6. nov 2025, 21:52 UTC

Omandamised, ülevõtmised, äriostud

Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED

6. nov 2025, 21:51 UTC

Omandamised, ülevõtmised, äriostud

Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany

6. nov 2025, 21:50 UTC

Market Talk

Tulu

Omandamised, ülevõtmised, äriostud

Tech, Media & Telecom Roundup: Market Talk

6. nov 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Lexicon Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

66.67% tõus

12 kuu keskmine prognoos

Keskmine 2.3 USD 66.67%

Kõrge 4 USD

Madal 1 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Lexicon Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Lexicon Pharmaceuticals Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.6863 / 0.72Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bullish.

There is one bearish event.

Sentiment

By Acuity

331 / 374 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.